Applying Desirability of Outcome Ranking End Points

被引：0
|
作者：
Dunne, Michael W. [1 ]
Aronin, Steven, I [1 ]
Das, Anita F. [2 ]
Gupta, Jayanti [1 ]
Akinapelli, Karthik [3 ]
Zelasky, Michael T. [4 ]
Puttagunta, Sailaja [1 ]
Boucher, Helen W. [5 ]
机构：
[1] Iterum Therapeut, Old Saybrook, CT 06475 USA
[2] Stat Consulting, Guerneville, CA USA
[3] Takeda Pharmaceut, Cambridge, MA USA
[4] Johnson & Johnson, Cambridge, MA USA
[5] Tufts Med & Tufts Univ, Sch Med, Boston, MA USA
来源：
CLINICAL INFECTIOUS DISEASES | 2023年 / 77卷 / 01期
关键词：
D O I：
10.1093/cid/ciad166
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：159 / 161
页数：3
相关论文
共 50 条
  • [21] Ranking, selecting, and prioritising genes with desirability functions
    Lazic, Stanley E.
    PEERJ, 2015, 3
  • [22] Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia
    Giacobbe, Daniele Roberto
    Signori, Alessio
    Tumbarello, Mario
    Ungaro, Riccardo
    Sarteschi, Giovanni
    Furfaro, Elisa
    Mikulska, Malgorzata
    Sanguinetti, Maurizio
    Posteraro, Brunella
    Losito, Angela Raffaella
    De Pascale, Gennaro
    Del Bono, Valerio
    Viscoli, Claudio
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (02) : 413 - 417
  • [23] Interpreting desirability of outcome ranking (DOOR) analyses in observational studies in infectious diseases: caution still needed
    Daniele Roberto Giacobbe
    Alessio Signori
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 1985 - 1986
  • [24] Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia
    Daniele Roberto Giacobbe
    Alessio Signori
    Mario Tumbarello
    Riccardo Ungaro
    Giovanni Sarteschi
    Elisa Furfaro
    Malgorzata Mikulska
    Maurizio Sanguinetti
    Brunella Posteraro
    Angela Raffaella Losito
    Gennaro De Pascale
    Valerio Del Bono
    Claudio Viscoli
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 413 - 417
  • [25] A global ranking approach to end points in trials of mechanical circulatory support devices
    Felker, G. Michael
    Anstrom, Kevin J.
    Rogers, Joseph G.
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (05) : 368 - 372
  • [26] Unlocking the DOORdhow to design, apply, analyse, and interpret desirability of outcome ranking endpoints in infectious diseases clinical trials
    Ong, Sean W. X.
    Petersiel, Neta
    Loewenthal, Mark R.
    Daneman, Nick
    Tong, Steven Y. C.
    Davis, Joshua S.
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (08) : 1024 - 1030
  • [27] Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR) (vol 61, 800, 2015)
    不详
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (01) : 182 - 182
  • [28] Longitudinal Benefit:risk Analysis through the Desirability of Outcome Ranking (DOOR) with Application to ACTT-1 Trial
    Shu, Shiyu
    Diao, Guoqing
    Hamasaki, Toshimitsu
    Scott, Scott
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2024,
  • [29] Evaluating the desirability of outcome ranking and response adjusted for duration of antibiotic risk for clinical trials of antibiotics in pediatric pneumonia
    Vanburen, John M.
    Banks, Russell K.
    Kuppermann, Nathan
    Gerber, Jeffrey S.
    Ruddy, Richard M.
    Casper, T. Charles
    Florin, Todd A.
    Pediatric Emergency Care Applied Research Network
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2025,
  • [30] The influence of outcome desirability on optimism
    Krizan, Zlatan
    Windschitl, Paul D.
    PSYCHOLOGICAL BULLETIN, 2007, 133 (01) : 95 - 121
12345